Tomayko MM - Search Results

1

Determination of subcutaneous tumor size in athymic (nude) mice.

Tomayko MM, Reynolds CP. Tomayko MM, et al. Cancer Chemother Pharmacol. 1989;24(3):148-54. doi: 10.1007/BF00300234. Cancer Chemother Pharmacol. 1989. PMID: 2544306

2

Human neuroblastoma cell lines regain catecholamine fluorescence when xenografted into athymic (nude) mice.

Tomayko MM, Triche TJ, Reynolds CP. Tomayko MM, et al. Int J Dev Neurosci. 1996 Oct;14(6):771-7. doi: 10.1016/s0736-5748(96)00050-0. Int J Dev Neurosci. 1996. PMID: 8960984

3

Human neuroblastoma cell lines that express N-myc without gene amplification.

Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP. Wada RK, et al. Among authors: tomayko mm. Cancer. 1993 Dec 1;72(11):3346-54. doi: 10.1002/1097-0142(19931201)72:11<3346::aid-cncr2820721134>3.0.co;2-e. Cancer. 1993. PMID: 8242562

4

Induction of catecholamine fluorescence in human neuroblastoma cell lines transplanted into nude mice.

Tomayko MM, Triche TJ, Newburgh RW, Reynolds CP. Tomayko MM, et al. Prog Clin Biol Res. 1988;271:307-16. Prog Clin Biol Res. 1988. PMID: 3406004 No abstract available.

5

Biological classification of cell lines derived from human extra-cranial neural tumors.

Reynolds CP, Tomayko MM, Donner L, Helson L, Seeger RC, Triche TJ, Brodeur GM. Reynolds CP, et al. Among authors: tomayko mm. Prog Clin Biol Res. 1988;271:291-306. Prog Clin Biol Res. 1988. PMID: 3406003 No abstract available.

6

Characterization of human neuroblastoma cell lines that lack N-myc gene amplification.

Wada RK, Seeger RC, Brodeur GM, Slamon DJ, Rayner SA, Tomayko M, Reynolds CP. Wada RK, et al. Prog Clin Biol Res. 1988;271:57-69. Prog Clin Biol Res. 1988. PMID: 3406020 No abstract available.

7

Bullous systemic lupus erythematosus in a 6-year-old boy.

Li AW, Weed JG, Stamey CR, Subtil A, Tomayko MM, Antaya RJ. Li AW, et al. Among authors: tomayko mm. Pediatr Dermatol. 2017 Nov;34(6):e313-e316. doi: 10.1111/pde.13258. Epub 2017 Aug 29. Pediatr Dermatol. 2017. PMID: 28851077

8

Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.

Coleman E, Ko C, Dai F, Tomayko MM, Kluger H, Leventhal JS. Coleman E, et al. Among authors: tomayko mm. J Am Acad Dermatol. 2019 Apr;80(4):990-997. doi: 10.1016/j.jaad.2018.10.062. Epub 2018 Nov 3. J Am Acad Dermatol. 2019. PMID: 30399387 Free PMC article.

9

Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.

Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS. Siegel J, et al. Among authors: tomayko mm. J Am Acad Dermatol. 2018 Dec;79(6):1081-1088. doi: 10.1016/j.jaad.2018.07.008. Epub 2018 Jul 17. J Am Acad Dermatol. 2018. PMID: 30025829

10

Image Gallery: Juvenile autoimmune pemphigus presenting with diffuse gingival hypertrophy and antibodies against desmocollin 3.

Leventhal JS, Haberland CM, Cowper SE, Tomayko MM. Leventhal JS, et al. Among authors: tomayko mm. Br J Dermatol. 2017 Nov;177(5):e226. doi: 10.1111/bjd.15954. Br J Dermatol. 2017. PMID: 29192983 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results